Doyle A E
Hypertension. 1983 Jul-Aug;5(4 Pt 2):II103-8. doi: 10.1161/01.hyp.5.4_pt_2.ii103.
The calcium antagonist drug, verapamil, was compared in double-blind, double-dummy, crossover studies with two beta-adrenoceptor blocking drugs, pindolol and labetalol. All were equally effective as antihypertensive drugs in patients with mild-to-moderate hypertension. Verapamil caused a fall in blood pressure by reducing total peripheral resistance, as judged by echocardiographic studies, and had no adverse effects on airways resistance in patients with obstructive airways disease. The favorable hemodynamic effects and absence of serious side effects suggest that verapamil may be an important advance in the treatment of hypertension.
在双盲、双模拟、交叉研究中,将钙拮抗剂药物维拉帕米与两种β肾上腺素受体阻断药物吲哚洛尔和拉贝洛尔进行了比较。在轻度至中度高血压患者中,所有药物作为抗高血压药物的效果相同。通过超声心动图研究判断,维拉帕米通过降低总外周阻力使血压下降,并且对阻塞性气道疾病患者的气道阻力没有不良影响。其良好的血流动力学效应和无严重副作用表明,维拉帕米可能是高血压治疗方面的一项重要进展。